Related references
Note: Only part of the references are listed.Effect of NKG2D ligand expression on host immune responses
Marine Champsaur et al.
IMMUNOLOGICAL REVIEWS (2015)
Interleukin 10 decreases MICA expression on melanoma cell surface
Antonio E. Serrano et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Natural Killer Cell Responses to Viral Infection
Joshua D. Brandstadter et al.
JOURNAL OF INNATE IMMUNITY (2011)
The Bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells
Rebekka Wehner et al.
JOURNAL OF INNATE IMMUNITY (2011)
Natural Killer Cells: Tolerance to Self and Innate Immunity to Viral Infection and Malignancy
Wayne M. Yokoyama et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
Miroslaw J. Szczepanski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible hard lesions
Federico Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunity unleashed in melanoma
Michael K. Erdmann
LANCET ONCOLOGY (2010)
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
M. Carlsten et al.
LEUKEMIA (2010)
New views on natural killer cell-based immunotherapy for melanoma treatment
Shannon Burke et al.
TRENDS IN IMMUNOLOGY (2010)
The Determination of Melanoma Stage at Diagnosis
John A. H. Lee
DERMATOLOGY RESEARCH AND PRACTICE (2010)
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+NK cells
Gordana Konjevic et al.
BIOMARKERS (2009)
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank
Rosa Mendez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines
Javier G. Casado et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
Annette Paschen et al.
CLINICAL CANCER RESEARCH (2009)
Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
Nicole Schwinn et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
Mattias Carlsten et al.
JOURNAL OF IMMUNOLOGY (2009)
Natural Cytotoxicity Receptors NKp30, NKp44 and NKp46 Bind to Different Heparan Sulfate/Heparin Sequences
Marie-Lyn Hecht et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
Gal Markel et al.
PLOS ONE (2009)
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
Paolo Carrega et al.
PLOS ONE (2009)
Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells
L. J. Berry et al.
TISSUE ANTIGENS (2009)
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Karl-Johan Malmberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Line of attack: NK cell specificity and integration of signals
Yenan T. Bryceson et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Negative signaling by inhibitory receptors: the NK cell paradigm
Eric O. Long
IMMUNOLOGICAL REVIEWS (2008)
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Akiko Iguchi-Manaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Expression of ligands to NKp46 in benign and malignant melanocytes
Emanuela Cagnano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Natural killer cell-directed therapies: moving from unexpected results to successful strategies
Magali Terme et al.
NATURE IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
The NKG2D receptor: immunobiology and clinical implications
Steven J. Burgess et al.
IMMUNOLOGIC RESEARCH (2008)
Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44
Andreina Byrd et al.
PLOS ONE (2007)
NKG2D-Mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients
Cristina Maccalli et al.
CLINICAL CANCER RESEARCH (2007)
Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients
Hitoe Torisu-Itakura et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation
Janet North et al.
JOURNAL OF IMMUNOLOGY (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands
Rafael Solana et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Activation, coactivation, and costimulation of resting human natural killer cells
Yenan T. Bryceson et al.
IMMUNOLOGICAL REVIEWS (2006)
Decreased frequency and proliferative response of invariant Vα24Vβ11 natural killer T (iNKT) cells in healthy elderly
Esther Peralbo et al.
BIOGERONTOLOGY (2006)
Tumor and viral recognition by natural killer cells receptors
Tal I. Arnon et al.
SEMINARS IN CANCER BIOLOGY (2006)
Human natural killer cell development and biology
Sherif S. Farag et al.
BLOOD REVIEWS (2006)
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis
D Pende et al.
MOLECULAR IMMUNOLOGY (2005)
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
S Tahara-Hanaoka et al.
INTERNATIONAL IMMUNOLOGY (2004)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
RT Costello et al.
BLOOD (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Share Paper
